Skip to main content
eLife logoLink to eLife
. 2020 Jan 20;9:e51595. doi: 10.7554/eLife.51595

Muscle function and homeostasis require cytokine inhibition of AKT activity in Drosophila

Katrin Kierdorf 1,2,†,‡,§,, Fabian Hersperger 3,4, Jessica Sharrock 1,2,#, Crystal M Vincent 1,2, Pinar Ustaoglu 1,2, Jiawen Dou 1, Attila Gyoergy 5, Olaf Groß 3,6,7, Daria E Siekhaus 5, Marc S Dionne 1,
Editors: K VijayRaghavan8, K VijayRaghavan9
PMCID: PMC6996930  PMID: 31944178

Abstract

Unpaired ligands are secreted signals that act via a GP130-like receptor, domeless, to activate JAK/STAT signalling in Drosophila. Like many mammalian cytokines, unpaireds can be activated by infection and other stresses and can promote insulin resistance in target tissues. However, the importance of this effect in non-inflammatory physiology is unknown. Here, we identify a requirement for unpaired-JAK signalling as a metabolic regulator in healthy adult Drosophila muscle. Adult muscles show basal JAK-STAT signalling activity in the absence of any immune challenge. Plasmatocytes (Drosophila macrophages) are an important source of this tonic signal. Loss of the dome receptor on adult muscles significantly reduces lifespan and causes local and systemic metabolic pathology. These pathologies result from hyperactivation of AKT and consequent deregulation of metabolism. Thus, we identify a cytokine signal that must be received in muscle to control AKT activity and metabolic homeostasis.

Research organism: D. melanogaster

eLife digest

The immune system helps animals fend off infections, but it also has a role in controlling the body’s metabolism – that is, the chemical reactions that sustain life. For instance, in fruit flies, high-fat diets can trigger the immune system, which results in cells becoming resistant to the hormone insulin and not being able to process sugar properly; this in turn leads to problems in sugar levels and shorter lifespans. This mechanism involves the release of an immune signal called unpaired-3 (upd3), which then binds to a receptor known as dome. Yet, it was unclear how exactly the immune system and metabolism work together, and whether their interactions are also important in flies on a normal diet.

To investigate, Kierdorf et al. stopped the activity of the dome receptor in the muscles of healthy flies. This led to an increase in the activity of the enzyme AKT, a protein critical to relay insulin-type signals inside the cell. As a result, insulin signaling was hyperactivated in the tissue, leading to decreased muscle function, unhealthy changes in how energy was stored and spent, and ultimately, a shorter life for the insects. Further experiments also identified blood cells called plasmatocytes (the flies’ equivalent of certain human immune cells) as a key source of the upd signal.

The findings by Kierdorf et al. shed a light on the fact that, even in healthy animals, complex interactions are required between the immune system and the metabolism. Further investigations will reveal if other body parts besides muscles rely on similar connections.

Introduction

JAK/STAT activating signals are critical regulators of many biological processes in animals. Originally described mainly in immune contexts, it has increasingly become clear that JAK/STAT signalling is also central to metabolic regulation in many tissues (Dodington et al., 2018; Villarino et al., 2017). One common consequence of activation of JAK/STAT pathways in inflammatory contexts is insulin resistance in target tissues, including muscle (Kim et al., 2013; Mashili et al., 2013). However, it is difficult to describe a general metabolic interaction between JAK/STAT and insulin signalling in mammals, due to different effects at different developmental stages, differences between acute and chronic actions, and the large number of JAKs and STATs present in mammalian genomes (Dodington et al., 2018; Mavalli et al., 2010; Nieto-Vazquez et al., 2008; Vijayakumar et al., 2013).

The fruit fly Drosophila melanogaster has a single, well-conserved JAK/STAT signalling pathway. The unpaired (upd) genes upd1-3 encode the three known ligands for this pathway; they signal by binding to a single common GP130-like receptor, encoded by domeless (dome) (Agaisse et al., 2003; Brown et al., 2001; Chen et al., 2002). Upon ligand binding, the single JAK tyrosine kinase in Drosophila, encoded by hopscotch (hop), is activated; Hop then activates the single known STAT, STAT92E, which functions as a homodimer (Binari and Perrimon, 1994; Chen et al., 2002; Hou et al., 1996; Yan et al., 1996). This signalling pathway plays a wide variety of functions, including segmentation of the early embryo, regulation of hematopoiesis, maintenance and differentiation of stem cells in the gut, and immune modulation (Amoyel and Bach, 2012; Myllymäki and Rämet, 2014). Importantly, several recent studies indicate roles for upd cytokines in metabolic regulation; for example, upds are important nutrient-responsive signals in the adult fly (Beshel et al., 2017; Rajan and Perrimon, 2012; Woodcock et al., 2015; Zhao and Karpac, 2017).

Here, we identify a physiological requirement for Dome signalling in adult muscle. We observe that adult muscles show significant JAK/STAT signalling activity in the absence of obvious immune challenge. Plasmatocytes are a source of this signal. Inactivation of dome on adult muscles significantly reduces lifespan and causes muscular pathology and physiological dysfunction; these result from remarkably strong AKT hyperactivation and consequent dysregulation of metabolism. We thus describe a new role for JAK/STAT signalling in adult Drosophila muscle with critical importance in healthy metabolic regulation.

Results

Dome is required in adult muscle

To find physiological functions of JAK/STAT signalling in the adult fly, we identified tissues with basal JAK/STAT pathway activity using a STAT-responsive GFP reporter (10xSTAT92E-GFP) (Bach et al., 2007). The strongest reporter activity we observed was in legs and thorax. We examined flies also carrying a muscle myosin heavy chain RFP reporter (MHC-RFP) and observed co-localization of GFP and RFP expression in the muscles of the legs, thorax and body wall (Figure 1—figure supplement 1). We observed strong, somewhat heterogeneous reporter expression in all the muscles of the thorax and the legs, with strong expression in various leg and jump muscles and apparently weaker expression throughout the body wall muscles and indirect flight muscles (Figure 1A). dome encodes the only known Drosophila STAT-activating receptor. To investigate the physiological role of this signal, we expressed domeΔ, a dominant-negative version of Dome lacking the intracellular signalling domain, with a temperature-inducible muscle specific driver line (w;tubulin-Gal80ts;24B-Gal4) (Figure 1—figure supplement 1) (Brown et al., 2001). Controls (24B-Gal80ts/+) and experimental flies (24B-Gal80ts > dome) were raised at 18°C until eclosion to permit Dome activity during development. Flies were then shifted to 29°C to inhibit Dome activity and their lifespan was monitored. Flies with Dome signalling inhibited in adult muscles were short-lived (Figure 1B, Figure 1—figure supplement 1). This effect was also observed, more weakly, in flies kept at 25°C (Figure 1—figure supplement 1). Upd-JAK-STAT signalling is important to maintain gut integrity, and defects in gut integrity often precede death in Drosophila; however, our flies did not exhibit loss of gut integrity (Figure 1—figure supplement 1) (Jiang et al., 2009; Rera et al., 2012). To determine whether Dome inhibition caused meaningful physiological dysfunction, we assayed climbing activity in 24B-Gal80ts/+ control flies and 24B-Gal80ts > dome flies. 24B-Gal80ts > dome flies showed significantly impaired climbing compared to controls (Figure 1C). Adult muscle-specific expression of domeΔ with a second Gal4 line (w;tub-Gal80ts;Mef2-Gal4) gave a similar reduction in lifespan and decline in climbing activity, confirming that the defect resulted from a requirement for Dome activity in muscle (Figure 1—figure supplement 1).

Figure 1. Dome inhibition in adult muscle reduces lifespan, disrupts homeostasis, and causes AKT hyperactivation.

(A) STAT activity in different muscles in 10xSTAT92E-GFP reporter fly. One fly out of 5 shown. Upper panel: lateral view, Scale bar = 500 µm. Lower panels: dorsal thorax (left); dorsal abdomen (middle); tibia (right), Scale bar = 100 µm. (B) Lifespan of 24B-Gal80ts/+ and 24B-Gal80ts > dome at 29°C. Log-Rank test: χ2 = 166, ***p<0.0001; Wilcoxon test: χ2 = 157.7, ***p<0.0001. (C) Negative geotaxis assay of 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. Points represent mean height climbed in individual vials (~20 flies/vial), pooled from three independent experiments. Unpaired T-test: **p=0.0033. (D) Muscle (Phalloidin) and neutral lipid (LipidTox) of thorax samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. One representative fly per genotype is shown of six analysed. Scale bar = 50 µm. (E) Thin layer chromatography (TLC) of triglycerides in 7-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies, n = 3–4 per genotype. One experiment of two is shown. Unpaired T-Test: ***p<0.0001. (F) Glucose and trehalose (left) and glycogen (right) in 7-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies, pooled from two independent experiments. Unpaired T-Test (Glucose +Trehalose): ***p<0.0001 and unpaired T-Test (Glycogen): ***p<0.0001. (G) CO2 produced, O2 consumed, and RQ of 7-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. Box plots show data from one representative experiment of three, with data collected from a 24 hr measurement pooled from 3 to 4 tubes per genotype with 10 flies/tube. P values from Mann-Whitney test. (H–L) Western blots of leg protein from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. (H) Phospho-AKT (S505). One experiment of four is shown. Unpaired T-Test: ***p<0.0001. (I) Total AKT. One experiment of two is shown. Unpaired T-Test: **p=0.0017. (J) Phospho-p70 S6K (T398). One experiment of two is shown. Unpaired T-Test: ns p=0.0539. (K) Phospho-AMPKα (T173). One experiment of three is shown. Unpaired T-Test: ns p=0.1024. (L) Phospho-ERK (T202/Y204). One experiment of three is shown. Unpaired T-Test: ns p=0.0826.

Figure 1.

Figure 1—figure supplement 1. Further characterisation of the requirement for dome in adult muscle.

Figure 1—figure supplement 1.

(A) STAT activity (10xSTAT92E-GFP) and muscle (MHC-RFP) colocalize in adult flies. One fly of 6 shown. Scale bar = 500 µm. (B) dome expression by qRT-PCR in thorax samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. Unpaired T-Test: *p=0.0102. (C) Lifespan of UAS-dome/+ and 24B-Gal80ts > dome at 29°C. Log-Rank test: χ2 = 100.8, ***p<0.0001; Wilcoxon test: χ2 = 76.2, ***p<0.0001. (D) Lifespan of 24B-Gal80ts/+ and 24B-Gal80ts > dome at 25°C. Log-Rank test: χ2 = 61.83, ***p<0.0001; Wilcoxon test: χ2 = 55.18, ***p<0.0001. (E) Smurf assay of 14-day-old 24B-Gal80ts/+ (n = 49) and 24B-Gal80ts-dome flies (n = 18). Data pooled from two independent experiments. (F) Lifespan of Mef2-Gal80ts/+ and Mef2-Gal80ts > dome flies at 29°C. Log-Rank test: χ2 = 86.96, ***p<0.0001; Wilcoxon test: χ2 = 78.61, ***p<0.0001. (G) Negative geotaxis assay of 14-day-old Mef2-Gal80ts/+ and Mef2-Gal80ts > dome flies. Points represent mean climbing height of individual vials analysed (~20 flies/vial), pooled from three independent experiments. Unpaired T-Test: ***p<0.0001. (H, I) Western blots of protein from legs of 14-day-old Mef2-Gal80ts/+ and Mef2-Gal80ts > dome flies. One of three independent experiments is shown. (H) Phospho-AKT. Unpaired T-Test: *p=0.0145. (I) Total AKT. Unpaired T-Test: ***p<0.0003. (J) Western blots of Phospho-AKT in leg samples from 14-day-old MHC-Gal4/+ and MHC-Gal4 >dome (II) flies. One of two independent experiments is shown. Unpaired T-Test: ns p=0.2557. (K) Lifespan of MHC-Gal4/+ and MHC-Gal4 >dome (II) flies at 29°C. Log-Rank test: χ2 = 82.9, ***p<0.0001; Wilcoxon test: χ2 = 58.91, ***p<0.0001. (L–R) Expression by qRT-PCR of Akt1 and insulin-like peptides in whole fly samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts-dome flies. All transcript levels are normalized to Rpl1 and shown in arbitrary units [au]. P values in B, G, H-J, L-R from unpaired T-test. (S) Feeding assay of 24-Gal80ts/+ and 24B2-Gal80ts > dome flies at 29°C. n = 4 were analysed per genotype. Absorbance at 620 nm is shown in arbitrary units [au]. Unpaired T-Test: ns p=0.8819.

Impaired muscle function is sometimes accompanied by lipid accumulation (Baik et al., 2017). Therefore, we stained thorax muscles with the neutral lipid dye LipidTox. In 14 day old flies, we detected numerous small neutral lipid inclusions in several muscles, including the large jump muscle (TTM), of 24B-Gal80ts > dome flies (Figure 1D).

Muscle dome activity is required for normal systemic homeostasis

Having observed lipid inclusions in adult muscles, we analysed the systemic metabolic state of 24B-Gal80ts > dome flies. We observed significant reductions in total triglyceride, glycogen and free sugar (glucose + trehalose) in these animals (Figure 1E,F).

Reduced free sugar could result from increased cellular sugar uptake. Increased uptake of sugars by peripheral tissues should be reflected in increased metabolic stores or metabolic rate. Since metabolic stores were decreased in our flies, we tested metabolic rate by measuring respiration. CO2 production and O2 consumption were both significantly increased in 24B-Gal80ts > dome flies, indicating an overall increase in metabolic rate (Figure 1G). dome acts via hop to regulate AKT activity with little effect on other nutrient signalling pathways.

The observed metabolic changes imply differences in activity of nutrient-regulated signalling pathways in 24B-Gal80ts > dome flies. Several signalling pathways respond to nutrients, or their absence, to coordinate energy consumption and storage (Britton et al., 2002; Lizcano et al., 2003; Ulgherait et al., 2014). Of these, insulin signalling via AKT is the primary driver of sugar uptake by peripheral tissues.

We examined the activity of these signalling mechanisms in legs (a tissue source strongly enriched in muscle) from 24B-Gal80ts > dome flies. We found an extremely strong increase in abundance of the 60 kDa form of total and activated (S505-phosphorylated) AKT (Figure 1H,I). This change was also seen in legs from Mef2-Gal80ts > dome flies, confirming that dome functions in muscles (Figure 1—figure supplement 1). We also saw this effect in flies carrying a different insertion of the dome transgene, under the control of a third muscle-specific driver, MHC-Gal4, though the effect was weaker; the weakness of this effect may be a consequence of the fact that the MHC-Gal4 driver is not expressed in visceral muscle (Bland et al., 2010) (Figure 1—figure supplement 1). These MHC-Gal4 >dome (II) animals were also short-lived relative to controls (Figure 1—figure supplement 1).

Elevated total AKT could result from increased transcript abundance or changes in protein production or stability. We distinguished between these possibilities by assaying Akt1 mRNA; Akt1 transcript levels were elevated in 24B-Gal80ts > dome muscle, but only by about 75%, suggesting that the large effect on AKT protein abundance must be, at least in part, post-transcriptional (Figure 1—figure supplement 1). Similarly, AKT hyperactivation could be driven by insulin-like peptide overexpression; however, we assayed the expression of Ilp2-7 in whole flies and observed that none of these peptides were significantly overexpressed (Figure 1—figure supplement 1). Next, we analysed if the feeding behaviour is affected by the muscle-specific dome loss, but we could not find a difference in food uptake in 24B-Gal80ts > dome flies compared to controls (Figure 1—figure supplement 1).

Unlike AKT, the amino-acid-responsive TORC1/S6K and the starvation-responsive AMPK pathway showed no significant difference in activity in 24B-Gal80ts > dome flies (Figure 1K,L). However, flies with AMPK knocked down in muscle did exhibit mild AKT hyperactivation (Figure 2—figure supplement 1).

To identify signalling mediators acting between Dome and AKT, we first tested activity of the MAPK-ERK pathway, which can act downstream of the JAK kinase Hop (Luo et al., 2002). We found an insignificant reduction in ERK activity in 24B-Gal80ts > dome flies (Figure 1M). We then assayed survival and AKT activity in flies with hop (JAK), Dsor1 (MEK) and rl (ERK) knocked down in adult muscle. rl and Dsor1 knockdown gave mild or no effect on survival and pAKT (Figure 2—figure supplement 1). In contrast, hop knockdown gave a mild phenocopy of dome with regards to survival and pAKT (Figure 2—figure supplement 1).

We further analysed the requirement for hop in muscle dome signalling by placing 24B-Gal80ts > dome on a genetic background carrying the viable gain-of-function allele hopTum-l. Flies carrying hopTum-l alone exhibited no change in lifespan, AKT phosphorylation, or muscle lipid deposition (Figure 2A–C). However, hopTum-l completely rescued lifespan and pAKT levels in 24B-Gal80ts > dome flies (Figure 2D,E), indicating that the physiological activity of muscle Dome is mediated via Hop and that signal is required, but not sufficient, to control muscle AKT activity.

Figure 2. Hop is required, but not sufficient, for Dome to control AKT.

(A) Lifespan of w1118 and hopTum-L flies at 29°C. Log-Rank test: χ2 = 0.3223, ns p=0.5702; Wilcoxon test: χ2 = 0.4756, ns p=0.4906. (B) Phospho-AKT in leg samples from 14-day-old w1118 and hopTum-L flies. One experiment of two is shown. Unpaired T-Test: ns p=0.6854. (C) Actin (Phalloidin) and neutral lipid (LipidTox) in flight muscle from 14-day-old w1118 and hopTum-L flies. One representative fly shown of six analysed per genotype. Scale bar = 50 µm. (D) Lifespan of 24B-Gal80ts/+, 24B-Gal80ts > dome, and hopTum-L;24B-Gal80ts > dome flies at 29°C. Log-Rank test (24B-Gal80ts/+ vs. 24B-Gal80ts > dome): χ2 = 319.4, ***p<0.0001; Wilcoxon test (24B-Gal80ts/+ vs. 24B-Gal80ts > dome): χ2 = 280.2, ***p<0.0001. Log-Rank test (24B-Gal80ts/+ vs. hopTum-L 24B-Gal80ts > dome): χ2 = 18.87, ***p<0.0001; Wilcoxon test (24B-Gal80ts/+ vs. hopTum-L 24B-Gal80ts > dome): χ2 = 20.83, ***p<0.0001. (E) Phospho-AKT in leg samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > dome and hopTum-L;24B-Gal80ts > dome flies. P values from unpaired T-Test.

Figure 2.

Figure 2—figure supplement 1. Interactions of dome with AMPK, MAPK, and FOXO signalling in adult muscle.

Figure 2—figure supplement 1.

(A) Phospho-AKT in leg samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > AMPKα-IR, and 24B-Gal80ts > AMPKβ-IR flies. One of three independent experiments is shown. P values from unpaired T-Test. (B) Phospho-AKT in leg samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > rl IR, and 24B-Gal80ts > Dsor1 IR flies. One of three independent experiments is shown. P values from unpaired T-Test. (C) Lifespan of 24B-Gal80ts/+, 24B-Gal80ts > rl IR, and 24B-Gal80ts > Dsor1 IR flies at 29°C. Log-Rank test (24B-Gal80ts/+ vs. 24B-Gal80ts > rl IR): χ2 = 60.29, ***p<0.0001; Wilcoxon test (24B-Gal80ts/+ vs. 24B-Gal80ts > rl IR): χ2 = 58.32, ***p<0.0001; Log-Rank test (24B-Gal80ts/+ vs. 24B-Gal80ts > Dsor1 IR): χ2 = 1.186, ns p=0.2760; Wilcoxon test (24B-Gal80ts/+ vs. 24B-Gal80ts > Dsor1 IR): χ2 = 0.0033, ns p=0.9538. (D) Phospho-AKT in leg samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > hop IR flies. One of two independent experiments is shown. Unpaired T-Test: *p=0.0187. (E) Lifespan of 24B-Gal80ts/+ and 24B-Gal80ts > hop IR flies at 29°C. Log-Rank test (24B-Gal80ts/+ vs. 24B-Gal80ts > hop IR): χ2 = 546.4, ***p<0.0001; Wilcoxon test (24B-Gal80ts/+ vs. 24B-Gal80ts > hop IR): χ2 = 458.1, ***p<0.0001. P values in A, C, E from unpaired T-test.

Increased AKT activity causes the effects of dome inhibition

The phenotype of 24B-Gal80ts > dome flies is similar to that previously described in flies with loss of function in Pten or foxo (Demontis and Perrimon, 2010; Mensah et al., 2015), suggesting that AKT hyperactivation might cause the dome loss of function phenotype; however, to our knowledge, direct activation of muscle AKT had not previously been analysed. We generated flies with inducible expression of activated AKT (myr-AKT) in adult muscles (w;tubulin-Gal80ts/+;24B-Gal4/UAS-myr-AKT [24B-Gal80ts > myr-AKT]) (Stocker et al., 2002). These animals phenocopied 24B-Gal80ts > dome flies with regards to lifespan, climbing activity, metabolite levels, metabolic rate, and muscle lipid deposition (Figure 3A–F).

Figure 3. AKT hyperactivation causes pathology in 24B-Gal80ts > dome flies.

(A) Lifespan of 24B-Gal80ts/+ and 24B-Gal80ts > myr-AKT at 29°C. Log-Rank test: χ2 = 115.5, ***p<0.0001; Wilcoxon test: χ2 = 123.6, ***p<0.0001. (B) Negative geotaxis assay of 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > myr-AKT flies. Points represent mean height climbed in individual vials (~20 flies/vial), pooled from two independent experiments. Unpaired T-Test: *p=0.018. (C) TLC of triglycerides in 7-day-old 24B-Gal80ts/+ and 24B-Gal80ts > myr-AKT flies, n = 3–4 per genotype. One experiment of two is shown. Unpaired T-Test: *p=0.0144. (D) Glucose and trehalose (left panel) and glycogen (right panel) in 7-day-old 24B-Gal80ts/+ (n = 12) and 24B-Gal80ts > myr-AKT (n = 9) flies, pooled from two independent experiments. Unpaired T-Test (Glucose +Trehalose): ***p=0.0009 and unpaired T-Test (Glycogen): ***p<0.0001. (E) CO2 produced, O2 consumed, and RQ of 7-day-old 24B-Gal80ts/+ and 24B-Gal80ts > myr-AKT flies. Box plots show data from one representative experiment of three, with data points collected from a 24 hr measurement pooled from 3 to 4 tubes per genotype with 10 flies/tube. P values from Mann-Whitney test. (F) Phalloidin and LipidTox staining of thorax samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > myr-AKT flies. One representative fly per genotype is shown of 3 analysed per group in two independent experiments. Scale bar = 50 µm. (G) Lifespan of 24B-Gal80ts/+, 24B-Gal80ts > dome, UAS-domeΔ/+, 24B-Gal80ts > AKT-IR, UAS-AKT-IR/+, 24B-Gal80ts > AKT-IR;dome and UAS-AKT-IR;dome/+ flies at 29°C. Log-Rank test (24B-Gal80ts > dome vs. 24B-Gal80ts > AKT-IR;dome): χ2 = 101.0, ***p<0.0001; Wilcoxon test (24B-Gal80ts > dome vs. 24B-Gal80ts > AKT-IR;dome): χ2 = 59.87, ***p<0.0001. (H) Lifespan of 24B-Gal80ts/+, 24B-Gal80ts > dome, foxo-GFP;24B-Gal80ts/+, and foxo-GFP;24B-Gal80ts > dome flies at 29°C. Log-Rank test (24B-Gal80ts > dome vs. foxo-GFP;24B-Gal80ts > dome): χ2 = 114.0, ***p<0.0001; Wilcoxon test (24B-Gal80ts > dome vs. foxo-GFP;24B-Gal80ts > dome): χ2 = 93.59, ***p<0.0001. (I) Glucose + trehalose and glycogen in 7-day-old 24B-Gal80ts/+, 24B-Gal80ts > domeΔ, foxo-GFP;24B-Gal80/+, and foxo-GFP; 24B-Gal80ts > domeΔ flies. Statistical testing was performed with one-way ANOVA. (J) TLC of triglycerides in 7-day-old 24B-Gal80ts/+, 24B-Gal80ts > domeΔ, foxo-GFP;24B-Gal80ts/+, and foxo-GFP;24B-Gal80ts > domeΔ flies. Statistical testing was performed with one-way ANOVA.

Figure 3.

Figure 3—figure supplement 1. Mutual regulation by AKT, Foxo, and Dome.

Figure 3—figure supplement 1.

(A) dome expression by qRT-PCR in whole fly samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > dome, 24B-Gal80ts > Akt-IR, and 24B-Gal80ts > Akt-IR;dome flies. (B–F) Gene xpression analysis of dome, upd2, Pepck, Thor and InR in whole fly samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > dome, foxo-GFP;24B-Gal80ts/+, and foxo-GFP;24B-Gal80ts > dome flies. P values from unpaired T-test. (B) dome. (C) upd2. (D) Pepck. (E) Thor. (F) InR. (G) Western blot for GFP to detect the Foxo-GFP fusion protein in leg samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > dome, foxo-GFP;24B-Gal80ts/+, and foxo-GFP;24B-Gal80ts > dome flies. (H) Western blot for Phospho-AKT in leg samples from 14-day-old 24B-Gal80ts/+, 24B-Gal80ts > dome, foxo-GFP;24B-Gal80ts/+, and foxo-GFP;24B-Gal80ts > dome flies. One of two independent experiments is shown. P values in A-D from unpaired T-test. (I–M) Gene expression analysis of Akh and six confirmed or putative Akh target genes in whole fly samples from 14-day-old 24B-Gal80ts/+ and 24B-Gal80ts > dome flies. Transcript levels are shown in arbitrary units [au]. P values from unpaired T-test. (I) Akh. (J) Hsl. (K) bmm. (L) plin1. (M) plin2.

We concluded that AKT hyperactivation could cause the pathologies seen in 24B-Gal80ts > dome flies. Therefore, we tested whether reducing AKT activity could rescue 24B-Gal80ts > dome flies. We generated flies carrying muscle-specific inducible dominant negative dome (UAS-dome) with dsRNA against Akt1 (UAS-AKT-IR). These flies showed significantly longer lifespan than 24B-Gal80ts > dome and 24B-Gal80ts > AKT IR flies, similar to all control genotypes analyzed (Figure 3G). Dome and AKT antagonism synergised to control the mRNA level of dome itself, further suggesting strong mutual antagonism between these pathways (Figure 3—figure supplement 1).

AKT hyperactivation should reduce FOXO transcriptional activity. To test whether this loss of FOXO activity caused some of the pathologies observed in 24B-Gal80ts > dome flies, we increased foxo gene dosage by combining 24B-Gal80ts > dome with a transgene carrying a FOXO-GFP fusion protein under the control of the endogenous foxo regulatory regions. These animals exhibited rescue of physiological defects and lifespan compared to 24B-Gal80ts > dome flies (Figure 3H–J). They also exhibited increased dome expression (Figure 3—figure supplement 1). The effects of these manipulations on published foxo target genes were mixed (Figure 3—figure supplement 1); the strongest effect we observed was that Dome blockade increased upd2 expression (Figure 3—figure supplement 1), consistent with the observation that FOXO activity inhibits upd2 expression in muscle (none of the other genes tested have been shown to be FOXO targets in muscle) (Zhao and Karpac, 2017). This may explain some of the systemic effects of Dome blockade.

The effect of the foxo transgene was stronger than expected from a 1.5-fold increase in foxo expression, so we further explored the relationship between FOXO protein expression and AKT phosphorylation. We found that 24B-Gal80ts > dome markedly increased FOXO-GFP abundance, so that the increase in total FOXO was much greater than 1.5-fold (Figure 3—figure supplement 1). This drove an apparent feedback effect, restoring AKT in leg samples of foxoGFP;24B-Gal80ts > dome flies to near-normal levels (Figure 3—figure supplement 1).

We also analysed expression of the catabolic hormone Akh and its putative targets bmm, Hsl, plin1 and plin2 in 24B-Gal80ts > dome animals (Figure 3—figure supplement 1). We observed no clear regulation of Akh itself or of Hsl, bmm, or plin2; plin1 was reduced in expression by expression of dome. We conclude that the primary effect of muscle dome is on AKT-foxo signalling.

Plasmatocytes are a relevant source of upd signals

Plasmatocytes—Drosophila macrophages—are a key source of upd3 in flies on high fat diet and in mycobacterial infection (Péan et al., 2017; Woodcock et al., 2015). Plasmatocytes also express upd1-3 in unchallenged flies (Chakrabarti et al., 2016). We thus tested their role in activation of muscle Dome.

We found plasmatocytes close to STAT-GFP-positive leg muscle (Figure 4A,B). This, and the prior published data, suggested that plasmatocytes might produce relevant levels of dome-activating cytokines in steady state. We then overexpressed upd3 in plasmatocytes and observed a potent increase in muscle STAT-GFP activity (Figure 4C), confirming that plasmatocyte-derived upd signals were able to activate muscle Dome.

Figure 4. Plasmatocytes promote muscle Dome activity.

(A) Muscle (MHCYFP) and plasmatocytes (srpHemo-3xmCherry) in 7-day-old flies. Plasmatocytes are found in close proximity to adult muscles. One representative fly of 5 is shown. Scale bar = 500 µm. (B) Legs and plasmatocytes in 7-day-old 10xSTAT92E-GFP;srpHemo-3xmCherry flies. Muscle with high JAK-STAT activity (green) is surrounded by plasmatocytes (magenta). One representative fly of 5 is shown. Scale bar = 100 µm. (C) STAT activity and plasmatocytes in legs from control (10xSTAT92E-GFP;crq-Gal4 >CD8-mCherry/+) and upd3-overexpressing (10xSTAT92E-GFP;crq-4>CD8mCherry/UAS-upd3) flies. One representative fly of 10–14 is shown. Scale bar = 100 µm. Graph shows mean fluorescence intensity (MFI). Unpaired T-Test: ***p<0.0001. (D) STAT activity and plasmatocytes in legs from control (10xSTAT92E-GFP;crq-Gal80ts > CD8-mCherry/+) and plasmatocyte-depleted (10xSTAT92E-GFP;crq-Gal80ts > CD8 mCherry/rpr) flies. One representative fly of six is shown. Scale bar = 250 µm. (E) Western blot analysis of STAT-driven GFP in legs from 7-day-old control (10xSTAT92E-GFP;crq-Gal80ts > CD8-mCherry/+) and plasmatocyte-depleted (10xSTAT92E-GFP;crq-Gal80ts > CD8 mCherry/rpr flies). One representative experiment of three is shown. Graph shows STAT-GFP/α-tubulin for control (crq-Gal80ts/+) and plasmatocyte-depleted (crq-Gal80ts > rpr) leg samples. Unpaired T-Test: *p=0.0121. (F) Lifespan of crq-Gal80ts/+, crq-Gal80ts > rpr, upd2Δ upd3Δ;crq-Gal80ts/+, and upd2Δ upd3Δ;crq-Gal80ts > rpr flies at 29°C. Log-Rank test (crq-Gal80ts/+ vs. crq-Gal80ts > rpr): χ2 = 101.7, ***p<0.0001; Wilcoxon test (crq-Gal80ts/+ vs. crq-Gal80ts > rpr): χ2 = 107.8, ***p<0.0001; Log-Rank test (crq-Gal80ts/+ vs. upd2 Δ upd3Δ;crq-Gal80ts > rpr): χ2 = 60.03, ***p<0.0001; Wilcoxon test (crq-Gal80ts/+ vs. upd2 Δ upd3Δ;crq-Gal80ts > rpr): χ2 = 80.97, ***p<0.0001. (G) Actin (Phalloidin) and neutral lipid (LipidTox) in thorax samples from 14-day-old crq-Gal80ts/+, crq-Gal80ts > rpr, upd2 Δ upd3Δ;crq-Gal80ts/+, and upd2 Δ upd3Δ;crq-Gal80ts > rpr flies. One representative fly per genotype shown of 6 analysed per group. Scale bar = 50 µm. (H) Lifespan of crq-Gal4/+ and crq-Gal4 >upd1 IR flies at 29°C. Log-Rank test: χ2 = 31.36, ***p<0.0001; Wilcoxon test: χ2 = 22.17, ***p=0.0001. (I) Expression by qRT-PCR of upd1, upd2 and upd3 in thorax samples of crq-Gal4/+ and crq-Gal4 >upd1 IR flies, data from four independent samples of each genotype.. Unpaired T-Test (upd1): ns p=0.848, unpaired T-Test (upd2): *p=0.0449 and unpaired T-Test (upd3): **p=0.0038. (J) Lifespan of crq-Gal4/+, upd2 Δ upd3Δ;UAS-upd1-IR/+, and upd2Δ upd3Δ;crq-Gal4 >upd1 IR flies at 29°C. Log-Rank test (crq-Gal4/+ vs. upd2 Δ upd3Δ;crq-Gal4 >upd1 IR): χ2 = 41.12, ***p<0.0001; Wilcoxon test (crq-Gal4/+ vs. upd2Δ upd3Δ;crq-Gal4 >upd1 IR): χ2 = 54.47, ***p<0.0001 Log-Rank test (crq-Gal4/+ vs. upd2 Δ upd3Δ;UAS-upd1-IR/+): χ2 = 14.46, ***p<0.0001; Wilcoxon test (crq-Gal4/+ vs. upd2Δ upd3Δ;UAS-upd1-IR/+): χ2 = 19.99, ***p<0.0001. P values in C, E, H from unpaired T-test.

Figure 4.

Figure 4—figure supplement 1. Further characterisation of plasmatocyte-depleted flies.

Figure 4—figure supplement 1.

(A) Plasmatocyte depletion in crq-Gal80ts > rpr flies (right) and controls (left) at 24 hr, 48 hr and 72 hr at 29°C. One out of four flies is shown. Scale bar = 250 µm. (B) Quantification of mCherry-positive plasmatocytes in crq-Gal80ts > rpr flies (right) and controls (left) by flow cytometry after 72 hr at 29°C. n = 3 per group was analysed. Unpaired T-Test: *p=0.0337. (C) Negative geotaxis assay of 14-day-old crq-Gal80ts/+, crq-Gal80ts > rpr, upd2upd3;UAS-rpr/+ and upd2upd3;crq-Gal80ts > rpr flies. Points represent mean climbing height of individual vials analysed (~20 flies/vial). Unpaired T-Test: *p=0.0194.
Figure 4—figure supplement 2. Further characterisation of requirements for specific Upds.

Figure 4—figure supplement 2.

(A) Glucose + trehalose and glycogen in 7-day-old crq-Gal80ts/+, crq-Gal80ts > rpr, upd2Δ upd3Δ;crq-Gal80ts/+, and upd2Δ upd3Δ; crq-Gal80ts > rpr flies. (B) TLC of triglyceride in 7-day-old crq-Gal80ts/+, crq-Gal80ts > rpr, upd2Δ upd3Δ;crq-Gal80ts/+, and upd2Δ upd3Δ;crq-Gal80ts > rpr flies, n = 2–3 samples per genotype. (C) Western blot analysis of STAT-driven GFP in legs from 7-day-old w1118, upd3Δ, upd2Δ, and upd2Δ upd3Δ flies. One representative experiment of two is shown. (D) STAT activity and plasmatocytes in legs from 7-day-old control (crq-Gal4/+), upd1 knockdown (crq-Gal4 >upd1 IR), and upd3 knockdown (crq-Gal4 >upd3 IR) flies. One representative fly is shown of 5–7 imaged for each genotype. Scale bar = 100 µm. Mean fluorescence intensity (MFI) is shown for all flies imaged. (E) Western blot analysis of STAT-driven GFP in legs from 7-day-old control (crq-Gal4/+), upd1 knockdown (crq-Gal4 >upd1 IR), and upd3 knockdown (crq-Gal4 >upd3 IR) flies. One of two independent experiments is shown. (F) Western blot analysis of STAT-driven GFP in thorax from 7-day-old crq-Gal4/+, crq-Gal4 >upd1, upd2Δupd3Δ;crq-Gal4/+ and upd2Δupd3Δ;crq-Gal4 >upd1 IR flies. P values in A-F from unpaired T-test.

To determine the physiological relevance of plasmatocyte-derived signals, we assayed STAT-GFP activity in flies in which plasmatocytes had been depleted by expression of the pro-apoptotic gene reaper (rpr) using a temperature-inducible plasmatocyte-specific driver line (w;tub-Gal80ts;crq-Gal4). These animals exhibited a near-complete elimination of plasmatocytes within 24 hr of being shifted to 29°C (Figure 4—figure supplement 1). STAT-GFP fluorescence and GFP abundance were reduced in legs of plasmatocyte-depleted flies (crq-Gal80ts > rpr) compared to controls (crq-Gal80ts/+) (Figure 4D,E). Activity was not eliminated, indicating that plasmatocytes are not the only source of muscle STAT-activating signals, although these animals did exhibit a significant reduction in climbing activity (Figure 4—figure supplement 1).

We then examined the lifespan of flies in which we had depleted plasmatocytes in combination with various upd mutations and knockdowns. Plasmatocyte depletion gave animals that were short-lived (Figure 4F). (This effect was different from that we previously reported, possibly due to changes in fly culture associated with an intervening laboratory move [Woodcock et al., 2015]). Combining plasmatocyte depletion with null mutations in upd2 and upd3 did not significantly further reduce lifespan; upd2 upd3 mutants with plamatocytes intact exhibited near-normal lifespan (Figure 4F). Similarly, plasmatocyte depletion drove muscle lipid accumulation, and upd2 upd3 mutation synergised with plasmatocyte depletion to further increase muscle lipid inclusions (Figure 4G). Plasmatocyte depletion reduced free sugar levels as well as glycogen levels in the whole fly (Figure 4—figure supplement 2), but did not reduce the abundance of stored triglycerides (Figure 4—figure supplement 2). However, depleting plasmatocytes in upd2 upd3 mutants failed to recapitulate the effects of muscle Dome inhibition on whole-animal triglyceride, free sugar, and glycogen levels (Figure 4—figure supplement 2). This could be due to antagonistic effects of other plasmatocyte-derived signals.

We attempted to pinpoint a specific Upd as the relevant physiological ligand by examining STAT-GFP activity, first testing mutants in upd2 and upd3 because upd1 mutation is lethal. However, these mutants, including the upd2 upd3 double-mutant, were apparently normal (Figure 4—figure supplement 2). We then tested plasmatocyte-specific knockdown of upd1 and upd3; these animals were also essentially normal (Figure 4—figure supplement 2), and plasmatocyte upd1 knockdown did not reduce lifespan (Figure 4H). However, plasmatocyte-specific upd1 knockdown gave significant compensating increases in expression of upd2 and upd3 (Figure 4I). In keeping with this, combining plasmatocyte-specific upd1 knockdown with mutations in upd2 and upd3 reduced lifespan (Figure 4J) and also reduced STAT-GFP activity in these flies (Figure 4—figure supplement 2).

Our results indicate that plasmatocytes are an important physiological source of the Upd signal driving muscle Dome activity in healthy flies, and suggest that upd1 may be the primary relevant signal in healthy animals. However, plasmatocytes are not the only relevant source of signal, and Upd mutual regulation prevents us from pinpointing a single responsible signal.

Discussion

Here we show that upd-dome signalling in muscle acts via AKT to regulate physiological homeostasis in Drosophila. Loss of Dome activity in adult muscles shortens lifespan and promotes local and systemic metabolic disruption. Dome specifically regulates the level and activity of AKT; AKT hyper-activation mediates the observed pathology. Plasmatocytes are a primary source of the cytokine signal. In healthy adult flies, insulin-like peptides are the primary physiological AKT agonists. The effect we observe thus appears to be an example of a cytokine-Dome-JAK signal that impairs insulin function to permit healthy physiology.

Our work fits into a recent body of literature demonstrating key physiological roles for JAK-STAT activating signals in Drosophila. Upd1 acts locally in the brain to regulate feeding and energy storage by altering the secretion of neuropeptide F (NPF) (Beshel et al., 2017). Upd2 is released by the fat body in response to dietary triglyceride and sugar to regulate secretion of insulin-like peptides (Rajan and Perrimon, 2012). More recently, muscle-derived Upd2, under control of FOXO, has been shown to regulate production of the glucagon-like signal Akh (Zhao and Karpac, 2017). Indeed, we observe that upd2 is upregulated in flies with Dome signalling blocked in muscle, possibly explaining some of the systemic metabolic effects we observe. Plasmatocyte-derived Upd3 in flies on a high fat diet can activate the JAK/STAT pathway in various organs including muscles and can promote insulin insensitivity (Woodcock et al., 2015). Our observation that Upd signalling is required to control AKT accumulation and thus insulin pathway activity in healthy adult muscle may explain some of these prior observations and reveals a new role for plasmatocyte-derived cytokine signalling in healthy metabolic regulation.

Several recent reports have examined roles of JAK/STAT signalling in Drosophila muscle. In larvae, muscle JAK/STAT signalling can have an effect opposite to the one we report, with pathway loss of function resulting in reduced AKT activity (Yang and Hultmark, 2017). It is unclear whether this difference represents a difference in function between developmental stages (larva vs adult) or a difference between acute and chronic consequences of pathway inactivation. Roles in specific muscle populations have also been described: for example, JAK/STAT signalling in adult visceral muscle regulates expression of Vein, an EGF-family ligand, to control intestinal stem cell proliferation (Buchon et al., 2010; Jiang et al., 2011); the role of this system in other muscles may be analogous, controlling expression of various signals to regulate systemic physiology. Importantly, though we do not observe loss of gut integrity in our flies, it remains possible that the gut is an important mediator of some aspect of the physiological unpaired signal we document—either acting as an endocrine relay or via more subtle effects on gut physiology that could affect nutrient absorption. This would fit our observation that expression of dominant-negative Dome under the control of Mhc-Gal4 (which does not express in visceral muscle) gives a weaker effect on survival and AKT abundance than other muscle drivers and is particularly of interest given the documented role of plasmatocytes in regulation of gut homeostasis (Ayyaz et al., 2015).

The roles of mammalian JAK/STAT signalling in muscle physiology are more complex, but exhibit several parallels with the fly. In mice, early muscle-specific deletion of Growth Hormone Receptor (GHR) causes several symptoms including insulin resistance, while adult muscle-specific GHR deletion causes entirely different effects, including increased metabolic rate and insulin sensitivity on a high-fat diet (Mavalli et al., 2010; Vijayakumar et al., 2013; Vijayakumar et al., 2012). GHR signals via STAT5; STAT5 deletion in adult skeletal muscle promotes muscle lipid accumulation on a high-fat diet (Baik et al., 2017). Other STAT pathways can also play roles. For example, the JAK-STAT activating cytokine IL-6, which signals primarily via STAT3, increases skeletal muscle insulin sensitivity when given acutely but can drive insulin resistance when provided chronically (Nieto-Vazquez et al., 2008). STAT3 itself can promote muscle insulin resistance (Kim et al., 2013; Mashili et al., 2013). The relationship between these effects and those we have shown here, and the mechanisms regulating Upd production by plasmatocytes during healthy physiology, remain to be determined.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional
information
Genetic reagent
(D. melanogaster)
w1118; tubulin-Gal80ts/SM6a;24B-Gal4/TM6c, Sb1 This study Inserted Elements: P[w[+mC]=tubP-GAL80[ts]]; P[GawB]how24B
Genetic reagent (D. melanogaster) w1118; tubulin-Gal80ts/SM6a;Mef2-Gal4/TM6c, Sb1 This study Inserted Elements: P[w[+mC]=tubP-GAL80[ts]]; P[GAL4-Mef2.R]3
Genetic reagent (D. melanogaster) w1118;;UAS-dome/TM6c, Sb1 Brown et al., 2001 Gift of James Castelli-Gair Hombría
Genetic reagent (D. melanogaster) w1118;UAS-dome/CyO Brown et al., 2001 Gift of James Castelli-Gair Hombría
Genetic reagent (D. melanogaster) w1118;;UAS-myr-AKT/TM6c, Sb1 Stocker et al., 2002 Gift of Ernst Hafen
Genetic reagent (D. melanogaster) w;UAS-AMPKα-IR Vienna Drosophila Research Center (VDRC) RRID:FlyBase_FBst0478025; VDRC 106200
Genetic reagent (D. melanogaster) w;UAS-AMPKβ-IR VDRC RRID:FlyBase_FBst0476347; VDRC 104489
Genetic reagent (D. melanogaster) w;UAS-rl-IR VDRC RRID:FlyBase_FBst0480887; VDRC 109108
Genetic reagent (D. melanogaster) w;UAS-Dsor1-IR VDRC RRID:FlyBase_FBst0479098; VDRC 107276
Genetic reagent (D. melanogaster) w1118;foxoGFP BDSC RRID:BDSC_38644 Inserted Element:
PBac[foxo-GFP.FLAG]VK00037
Genetic reagent (D. melanogaster) w;UAS-AKT-IR VDRC RRID:FlyBase_FBst0475561; VDRC 103703
Genetic reagent (D. melanogaster) w1118;10xSTAT92E-GFP BDSC
Bach et al., 2007
RRID:BDSC_26197 Inserted Element:
P[10XStat92E-GFP]1
Genetic reagent (D. melanogaster) w1118;MHC-Gal4,MHC-RFP/SM6a BDSC RRID:BDSC_38464 Inserted Element:
P[Mhc-GAL4.F3-580]2; P[Mhc-RFP.F3-580]2
Genetic reagent (D. melanogaster) w upd2 Δ upd3Δ;;; BDSC RRID:BDSC_55729
Genetic reagent (D. melanogaster) w1118;;crq-Gal4/TM6 c, Sb1 Gift of Nathalie Franc
Genetic reagent (D. melanogaster) w1118;tub-Gal80ts;TM2/TM6 c, Sb1 BDSC RRID:BDSC_7108
Genetic reagent (D. melanogaster) w1118;;UAS-rpr/TM6 c, Sb1 BDSC RRID:BDSC_5824
Genetic reagent (D. melanogaster) w1118;UAS-CD8-mCherry BDSC RRID:BDSC_27391
Genetic reagent (D. melanogaster) w1118;;srpHemo-3xmCherry/TM6c, Sb1 Gyoergy et al., 2018
Genetic reagent (D. melanogaster) w;UAS-hop-IR VDRC RRID:FlyBase_FBst0463355; VDRC 40037
Genetic reagent (D. melanogaster) w;UAS-upd1-IR/SM6a VDRC RRID:FlyBase_FBst0459787; VDRC 3282
Genetic reagent (D. melanogaster) w;UAS-upd3-IR VDRC RRID:FlyBase_FBst0456774; VDRC 27134
Genetic reagent (D. melanogaster) w1118;;UAS-upd3/TM6 c, Sb1 Gift of Bruce Edgar
Genetic reagent (D. melanogaster) w1118;UAS-2xeGFP/SM6a BDSC RRID:BDSC_6874
Genetic reagent (D. melanogaster) w1118 hopTum-L/FM7h BDSC RRID:BDSC_8492 backcrossed onto w1118 background
Sequence-based reagent Akt1_forward This study PCR primers 5’-ctttgcgagtattaactggacaga-3’
Sequence-based reagent Akt1_reverse This study PCR primers 5’-ggatgtcacctgaggcttg-3’
Sequence-based reagent Ilp2_forward This study PCR primers 5’-atcccgtgattccaccacaag-3’
Sequence-based reagent Ilp2_reverse This study PCR primers 5’-gcggttccgatatcgagtta-3’
Sequence-based reagent Ilp3_forward This study PCR primers 5’-caacgcaatgaccaagagaa-3’
Sequence-based reagent Ilp3_reverse This study PCR primers 5’-tgagcatctgaaccgaact-3’
Sequence-based reagent Ilp4_forward This paper PCR primers 5’-gagcctgattagactgggactg-3’
Sequence-based reagent Ilp4_reverse This paper PCR primers 5’-tggaccggctgcagtaac-3’
Sequence-based reagent Ilp5_forward This paper PCR primers 5’-gccttgatggacatgctga-3’
Sequence-based reagent Ilp5_reverse This paper PCR primers 5’-agctatccaaatccgcca-3’
Sequence-based reagent Ilp6_forward This paper PCR primers 5’-cccttggcgatgtatttcc-3’
Sequence-based reagent Ilp6_reverse This paper PCR primers 5’-cacaaatcggttacgttctgc-3’
Sequence-based reagent Ilp7_forward This paper PCR primers 5’-cacaccgaggagggtctc-3’
Sequence-based reagent Ilp7_reverse This paper PCR primers 5’-caatatagctggcggacca-3’
Sequence-based reagent dome_forward This paper PCR primers 5’-cggactttcggtactccatc-3’
Sequence-based reagent dome_reverse This paper PCR primers 5’-accttgatgaggccaggat-3’
Sequence-based reagent upd1_forward This paper PCR primers 5’-gcacactgatttcgatacgg-3’
Sequence-based reagent upd1_reverse This paper PCR primers 5’- ctgccgtggtgctgtttt −3’
Sequence-based reagent upd2_forward This paper PCR primers 5’-cggaacatcacgatgagcgaat-3’
Sequence-based reagent upd2_reverse This paper PCR primers 5’-tcggcaggaacttgtactcg-3’
Sequence-based reagent upd3_forward This paper PCR primers 5’-actgggagaacacctgcaat-3’
Sequence-based reagent upd3_reverse This paper PCR primers 5’-gcccgtttggttctgtagat-3’
Sequence-based reagent Pepck_forward This paper PCR primers 5’-ggataaggtggacgtgaag-3’
Sequence-based reagent Pepck_reverse This paper PCR primers 5’-acctcctgcgaccagaact-3’
Sequence-based reagent Thor_forward This paper PCR primers 5’-caggaaggttgtcatctcgga-3’
Sequence-based reagent Thor_reverse This paper PCR primers 5’-ggagtggtggagtagagggtt-3’
Sequence-based reagent InR_forward This paper PCR primers 5'-gcaccattataaccggaacc-3'
Sequence-based reagent InR_reverse This paper PCR primers 5'-ttaattcatccatgacgtgagc-3'
Sequence-based reagent Akh_forward This paper PCR primers 5’- agccgtgctcttcatgct-3’
Sequence-based reagent Akh_reverse This paper PCR primers 5’-aaaggttccaggaccagctc-3’
Sequence-based reagent Hsl_forward This paper PCR primers 5’-cttggaaatacttgaggggttg-3’
Sequence-based reagent Hsl_reverse This paper PCR primers 5’-agatttgatgcagttctttgagc-3’
Sequence-based reagent bmm_forward This paper PCR primers 5’-gtctcctctgcgatttgccat-3’
Sequence-based reagent bmm_reverse This paper PCR primers 5’-ctgaagggacccagggagta-3’
Sequence-based reagent plin1_forward This paper PCR primers 5’-gcgttctatggtagccttcag-3’
Sequence-based reagent plin1_reverse This paper PCR primers 5’-gcgtccggatagaaagctg-3’
Sequence-based reagent plin2_forward This paper PCR primers 5’-gcagaatggcaagagttctga-3’
Sequence-based reagent plin2_reverse This paper PCR primers 5’-actgtgtgtaggactggatcctc-3’
Sequence-based reagent Rpl1_forward This paper PCR primers 5’-tccaccttgaagaagggcta-3’
Sequence-based reagent Rpl1_reverse This paper PCR primers 5’-ttgcggatctcctcagactt-3’
Peptide, recombinant protein Trehalase Sigma Aldrich T8778
Peptide, recombinant protein β-Amyloglucosidase Sigma Aldrich 10115
Antibody anti-phospho(Ser505)-AKT Cell Signal Technology (CST) Cat# 4054; RRID:AB_331414 WB (1:1000)
Antibody anti-AKT Cell Signal Technology (CST) Cat# 4691; RRID:AB_915783 WB (1:1000)
Antibody anti-phospho(Thr172)-AMPKα Cell Signal Technology (CST) Cat# 2535; RRID:AB_331250 WB (1:1000)
Antibody anti-phospho(Thr389)-p70 S6 kinase Cell Signal Technology (CST) Cat# 9206; RRID:AB_2285392 WB (1:1000)
Antibody anti-GFP Cell Signal Technology (CST) Cat# 2956; RRID:AB_1196615 WB (1:1000)
Antibody anti-phospho-p44/42 MAPK (Erk1/2) Cell Signal Technology (CST) Cat# 4370; RRID:AB_2315112 WB (1:1000)
Antibody anti-α-tubulin Developmental Studies Hybridoma Bank) Clone 12G10; RRID:AB_1157911 WB (1:3000)
Antibody HRP anti-rabbit IgG Cell Signal Technology (CST) Cat# 7074; RRID:AB_2099233 WB (1:5000)
Antibody HRP anti-mouse IgG Cell Signal Technology (CST) Cat# 7076; RRID:AB_330924 WB (1:5000)
Commercial assay or kit First Strand cDNA Synthesis Kit Thermo Scientific K1622
Commercial assay or kit Sensimix SYBR Green no-ROX Bioline QT650-05
Chemical compound, drug Bromophenol blue Sigma Aldrich SML1656
Chemical compound, drug Xylene cyanol Carl Roth A513.1
Chemical compound, drug Brilliant Blue FCF Sigma Aldrich 80717
Other HCS Lipid Tox Deep Red Thermo Fisher H34477 IF (1:200)
Other Alexa Fluor 488 Phalloidin Thermo Fisher A12379 IF (1:20)
Other Fluoromount-G ebioscience 00-4958-02
Other TRIzol Invitrogen AM9738
Other Fixable Viability Dye 780 ebioscience 65-0865-18 FC (1:1000)
Other Supersignal West Pico Chemiluminescent Substrate Thermo Scientific 34077
Other Supersignal West Femto Chemiluminescent Substrate Thermo Scientific 34094
Other Glucose Reagent Sentinel Diagnostics 17630H
Software, algorithm ImageJ ImageJ RRID:SCR_003070
Software, algorithm GraphPad Prism GraphPad RRID:SCR_002798
Software, algorithm FlowJo FlowJo RRID:SCR_008520)

Drosophila melanogaster stocks and culture

All fly stocks were maintained on food containing 10% w/v Brewer’s yeast, 8% fructose, 2% polenta and 0.8% agar supplemented with propionic acid and nipagin. Crosses for experiments were performed at 18°C (for crosses with temperature inducible gene expression) or 25°C. Flies were shifted to 29°C after eclosion where relevant.

Male flies were used for all experiments. All flies were backcrossed onto our laboratory isogenic w1118 genetic background, with the exception of VDRC knockdown lines (these lines are also on a uniform genetic background and could be compared with one another). All crosses were performed using driver females so that the male progeny used for experiments would have a uniform X chromosome.

The following original fly stocks were used for crosses:

Fly stocks Description and origin
w1118; tubulin-Gal80ts/SM6a;24B-Gal4/TM6c, Sb1 Temperature sensitive muscle specific driver line; 24B-Gal4 a gift of Nazif Alic
w1118; tubulin-Gal80ts/SM6a;Mef2-Gal4/TM6c, Sb1 Temperature sensitive muscle specific driver line; Mef2-Gal4 a gift of Michael Taylor
w1118;;UAS-dome/TM6c, Sb1 Line for expression of a dominant-negative dome, gift of James Castelli-Gair Hombría
w1118;UAS-dome/CyO Line for expression of a dominant-negative dome, gift of James Castelli-Gair Hombría
w1118;;UAS-myr-AKT/TM6c, Sb1 Line for over-expression of a constitutive active (myristoylated) AKT, gift of Ernst Hafen
w;UAS-AMPKα-IR VDRC KK106200
w;UAS-AMPKβ-IR VDRC KK104489
w;UAS-rl-IR VDRC KK109108
w;UAS-Dsor1-IR VDRC KK102276
w1118;foxoGFP Expresses GFP-tagged foxo fusion protein (genomic rescue construct inserted at AttP40). Bloomington Drosophila Stock Center (BDSC) 38644
w;UAS-AKT-IR VDRC KK103703
w1118;10xSTAT92E-GFP STAT-GFP reporter line (Bach et al., 2007). BDSC #26197
w1118;MHC-Gal4,MHC-RFP/SM6a Muscle specific driver line and muscle specific reporter line. Derived from BDSC #38464
w upd2 Δ upd3Δ;;; Gift of Bruno Lemaitre
w1118;;crq-Gal4/TM6c, Sb1 Plasmatocyte specific driver line, gift of Nathalie Franc
w1118;tub-Gal80ts;TM2/TM6c, Sb1 Line for ubiquitous expression of Gal80ts, BDSC #7108
w1118;;UAS-rpr/TM6c, Sb1 Line for over-expression of the pro-apoptotic protein rpr. Derived from BDSC #5824
w1118;UAS-CD8-mCherry Line for overexpression of a CD8-mCherry fusion protein. Derived from BDSC #27391
w1118;;srpHemo-3xmCherry/TM6c, Sb1 Plasmatocyte reporter line (Gyoergy et al., 2018)
w;UAS-hop-IR VDRC GD40037
w;UAS-upd1-IR/SM6a VDRC GD3282
w;UAS-upd3-IR VDRC GD6811
w1118;;UAS-upd3/TM6c, Sb1 Line for overexpression of upd3, gift of Bruce Edgar
w1118;UAS-2xeGFP/SM6a Line for expression of bicistronic GFP, BDSC #6874
w1118 hopTum-L/FM7h Gain-of function mutant of hop; derived by backcrossing from BDSC 8492 onto our control w1118 background

Genotype abbreviations were used for the different experimental flies in this study, in the following table the complete genotypes are indicated:

Genotype abbreviation of flies used in the manuscript Complete genotype of flies used in the manuscript
10XSTAT92E-GFP/MHC-RFP w1118;10xSTAT92E-GFP/MHC-Gal4,MHC-RFP
24B-Gal80ts/+ w1118;tub-Gal80ts/+;24B-Gal4/+
24B-Gal80ts > dome w1118;tub-Gal80ts/+;24B-Gal4/UAS-dome
24B-Gal80ts > myr-AKT w1118;tub-Gal80ts/+;24B-Gal4/UAS-myr-AKT
24B-Gal80ts > AMPKα-IR w1118;tub-Gal80ts/UAS-AMPKα-IR;24B-Gal4/+
24B-Gal80ts > AMPKβ-IR w1118;tub-Gal80ts/UAS-AMPKβ-IR;24B-Gal4/+
24B-Gal80ts > rl-IR w1118;tub-Gal80ts/UAS-rl-IR;24B-Gal4/+
24B-Gal80ts > Dsor1-IR w1118;tub-Gal80ts/UAS-Dsor1-IR;24B-Gal4/+
24B-Gal80 > hop-IR w1118;tub-Gal80ts/UAS-hop-IR;24B-Gal4/+
hoptum-L;24B-Gal80 > dome w1118 hoptum-L;tub-Gal80ts/+;24B-Gal4/UAS-dome
24B-Gal80ts > AKT-IR w1118;tub-Gal80ts/UAS-AKT-IR;24B-Gal4/+
24B-Gal80ts > AKT-IR;dome w1118;tub-Gal80ts/UAS-AKT-IR;24B-Gal4/UAS-dome
MHC-Gal4/+ w1118;MHC-Gal4,Mhc-RFP/+;
MHC-Gal4 > dome (II) w1118;MHC-Gal4,MHC-RFP/UAS-dome;
foxoGFP;24B-Gal80ts/+ w1118;foxoGFP;tub-Gal80ts/+;24B-Gal4/+
foxoGFP;24B-Gal80ts > dome w1118;foxoGFP;tub-Gal80ts/+;24B-Gal4/UAS-dome
UAS-dome/+ w1118;;UAS-dome/+
UAS-AKT-IR/+ w1118;UAS-AKT-IR/+;
UAS-AKT-IR;dome/+ w1118;UAS-AKT-IR/+; UAS-dome/+
Mef2-Gal80ts/+ w1118;tub-Gal80ts/+;Mef2-Gal4/+
Mef2-Gal80ts > dome w1118;tub-Gal80ts/+;Mef2-Gal4/UAS-dome
srpHemo-3xmCherry w1118;; srpHemo-3xmCherry/+
crq-Gal4/+ w1118;;crq-Gal4/+
crq-Gal80ts > rpr w1118;tub-Gal80ts/+;crq-Gal4/UAS-rpr or w1118;tub-Gal80ts/+;crq-Gal4,UAS-CD8-mCherry,10xSTAT92E-GFP/UAS-rpr
crq-Gal80ts/+ w1118;tub-Gal80ts/+;crq-Gal4/+ or w1118;tub-Gal80ts/+;crq-Gal4,UAS-CD8-mCherry,10xSTAT92E-GFP/+
crq-Gal4/+ w1118;;crq-Gal4,UAS-CD8-mCherry,10xSTAT92E-GFP/+
crq-Gal4 > upd1-IR w1118;UAS-upd1-IR/+;crq-Gal4,UAS-CD8-
mCherry,10xSTAT92E-GFP/+
crq-Gal4 > upd3-IR w1118;UAS-upd3-IR/+;crq-Gal4,UAS-CD8-mCherry,10xSTAT92E-GFP/+
crq-Gal4 > upd3 w1118;;crq-Gal4,UAS-CD8-mCherry,10xSTAT92E-GFP/UAS-upd3
upd2 Δ upd3Δ;crq-Gal80ts/+ w upd2 Δ upd3Δ;tub-Gal80ts/+;crq-Gal4/+
upd2 Δ upd3Δ;crq-Gal80ts > rpr w upd2 Δ upd3Δ;tub-Gal80ts/+;crq-Gal4/UAS-rpr
upd2 Δ upd3Δ;upd1-IR/+ w upd2 Δ upd3Δ;UAS-upd1-IR/+
upd2 Δ upd3Δ;crq-Gal4/+ w upd2 Δ upd3Δ;;crq-Gal4/+
upd2 Δ upd3Δ;crq-Gal4 > upd1-IR w upd2 Δ upd3Δ;UAS-upd1-IR/+;crq-Gal4/+
MHCYFP; srpHemo-3xmCherry w1118; MHCYFP/+;srpHemo-3xmCherry/+
10xSTAT92E-GFP; srpHemo-3xmCherry w1118; 10xSTAT92E-GFP/+;srpHemo-3xmCherry/+

Lifespan/Survival assays

Male flies were collected after eclosion and groups of 20–40 age-matched flies per genotype were placed together in a vial with fly food. All survival experiments were performed at 29°C. Dead flies were counted daily. Vials were kept on their sides to minimize the possibility of death from flies becoming stuck to the food, and flies were moved to fresh food twice per week. Flies were transferred into new vials without CO2 anaesthesia.

Negative geotaxis assay/Climbing Assay

Male flies were collected after eclosion and housed for 14 days in age-matched groups of around 20. The assay was performed in the morning, when flies were most active. Flies were transferred without CO2 into a fresh empty vial without any food and closed with the open end of another empty vial. Flies were placed under a direct light source and allowed to adapt to the environment for 20 min. Negative geotaxis reflex was induced by tapping the flies to the bottom of the tube and allowing them to climb up for 8 s. After 8 s the vial was photographed. This test was repeated 3 times per vial with 1 min breaks in between. The height each individual fly had climbed was measured in Image J, and the average between all three runs per vial was calculated.

Feeding assays

Male flies were aged for 7 days and changed on food supplemented with 0.1% bromophenol blue and 0.5% xylene cyanol. Control flies for each genotype were maintained on non-blue food for background subtraction. Flies were left on the blue or non-blue food for 4 hr at 29°C. After 4 hr flies were anaesthetized with CO2 and decapitated to avoid interference of the eye pigment with the measured absorbance. five flies were homogenized in 100 µl PBS per sample. The fly torsos were homogenized and centrifuged for 20 min at 12.000 rpm. The supernatant was collected and absorbance at 620 nm was analysed with a plate reader.

Staining of thorax samples

For immunofluorescent staining of thorax muscles, we anaesthetized flies and removed the head, wings and abdomen from the thorax. Thorax samples were pre-fixed for 1 hr in 4% PFA rotating at room temperature. Thoraces were then halved sagitally with a razor blade and fixed for another 30 min rotating at room temperature. Samples were washed with PBS + 0.1% Triton X-100, then blocked for 1 hr in 3% bovine serum albumin (BSA) in PBS + 0.1% Triton X-100.

For Lipid-Tox staining, samples were washed with PBS and stained for 2 hr at room temperature with HCS Lipid Tox Deep Red (Thermo Fisher #H34477; 1:200). For Phalloidin labelling, the samples were washed in PBS after fixation and stained for 2 hr at room temperature with Alexa Fluor 488 Phalloidin (Thermo Fisher #A12379, 1:20). Afterwards the samples were washed once with PBS and mounted in Fluoromount-G. All mounted samples were sealed with clear nail polish and stored at 4°C until imaging.

Confocal microscopy

Imaging was performed in the Facility for Imaging by Light Microscopy (FILM) at Imperial College London and in the Institute of Neuropathology in Freiburg. A Leica SP5 and SP8 microscope (Leica) were used for imaging, using either the 10x/NA0.4 objective, or the 20x/NA0.5 objective. Images were acquired with a resolution of either 1024 × 1024 or 512 × 512, at a scan speed of 400 Hz. Averages from 3 to 4 line scans were used, sequential scanning was employed where necessary and tile scanning was used in order to image whole flies. For imaging of whole live flies, the flies were anaesthetized with CO2 and glued to a coverslip. Flies were kept on ice until imaging. For measuring mean fluorescence intensity, a z-stack of the muscle was performed and the stack was projected in an average intensity projection. Next the area of the muscle tissue analyzed was defined and the mean fluorescent intensity within this area was measured. Images were processed and analysed using Image J.

RNA isolation and reverse transcription

For RNA extraction three whole flies or three thoraces were used per sample. After anaesthetisation, the flies were smashed in 100 µl TRIzol (Invitrogen), followed by a chloroform extraction and isopropanol precipitation. The RNA pellet was cleaned with 70% ethanol and finally solubilized in water. After DNase treatment, cDNA synthesis was carried out using the First Strand cDNA Synthesis Kit (Thermo Scientific) and priming with random hexamers (Thermo Scientific). cDNA samples were further diluted and stored at −20° C until analysis.

Quantitative Real-time PCR

Quantitative Real-time PCR was performed with Sensimix SYBR Green no-ROX (Bioline) on a Corbett Rotor-Gene 6000 (Corbett). The cycling conditions used throughout the study were as follows: Hold 95°C for 10 min, then 45 cycles of 95°C for 15 s, 59°C for 30 s, 72°C for 30 s, followed by a melting curve. All calculated gene expression values were measured in arbitrary units (au) according to diluted cDNA standards run in each run and for each gene measured. All gene expression values are further normalized to the value of the loading control gene, Rpl1, prior to further analysis.

The following primer sequences have been used in this study:

Gene name Forward Reverse
Akt1 5’-ctttgcgagtattaactggacaga-3’ 5’-ggatgtcacctgaggcttg-3’
Ilp2 5’-atcccgtgattccaccacaag-3’ 5’-gcggttccgatatcgagtta-3’
Ilp3 5’-caacgcaatgaccaagagaa-3’ 5’-tgagcatctgaaccgaact-3’
Ilp4 5’-gagcctgattagactgggactg-3’ 5’-tggaccggctgcagtaac-3’
Ilp5 5’-gccttgatggacatgctga-3’ 5’-agctatccaaatccgcca-3’
Ilp6 5’-cccttggcgatgtatttcc-3’ 5’-cacaaatcggttacgttctgc-3’
Ilp7 5’-cacaccgaggagggtctc-3’ 5’-caatatagctggcggacca-3’
dome 5’-cggactttcggtactccatc-3’ 5’-accttgatgaggccaggat-3’
upd1 5’-gcacactgatttcgatacgg-3’ 5’- ctgccgtggtgctgtttt −3’
upd2 5’-cggaacatcacgatgagcgaat-3’ 5’-tcggcaggaacttgtactcg-3’
upd3 5’-actgggagaacacctgcaat-3’ 5’-gcccgtttggttctgtagat-3’
Pepck1 5’-ggataaggtggacgtgaag-3’ 5’-acctcctgcgaccagaact-3’
Thor 5’-caggaaggttgtcatctcgga-3’ 5’-ggagtggtggagtagagggtt-3’
InR 5'-gcaccattataaccggaacc-3' 5'-ttaattcatccatgacgtgagc-3'
Akh 5’- agccgtgctcttcatgct-3’ 5’-aaaggttccaggaccagctc-3’
Hsl 5’-cttggaaatacttgaggggttg-3’ 5’-agatttgatgcagttctttgagc-3’
bmm 5’-gtctcctctgcgatttgccat-3’ 5’-ctgaagggacccagggagta-3’
plin1 5’-gcgttctatggtagccttcag-3’ 5’-gcgtccggatagaaagctg-3’
plin2 5’-gcagaatggcaagagttctga-3’ 5’-actgtgtgtaggactggatcctc-3’
Rpl1 5’-tccaccttgaagaagggcta-3’ 5’-ttgcggatctcctcagactt-3’

Smurf assay

Smurf assays with blue-coloured fly food were performed to analyse gut integrity in different genotypes. Normal fly food, as described above, was supplemented with 0.1% Brilliant Blue FCF (Sigma Aldrich). Experimental flies were placed on the blue-coloured fly food at 9AM and kept on the food for 2 hr at 29°C. After 2 hr, the distribution of the dye within the fly was analysed for each individual. Flies without any blue dye were excluded, flies with a blue gut or crop were identified as ‘non-smurf’ and flies which turned completely blue or showed distribution of blue dye outside the gut were classified as ‘smurf’.

Western blot

Dissected legs or thoraces from three flies were used per sample and smashed in 75 µl 2x Laemmli loading buffer (100 mM Tris [pH 6.8], 20% glycerol, 4% SDS, 0.2 M DTT). Samples were stored at −80°C until analysis. 7.5 µl of this lysate were loaded per lane. Blue pre-stained protein standard (11–190 kDa) (New England Biolabs) was used. Protein was transferred to nitrocellulose membrane (GE Healthcare). Membrane was blocked in 5% milk in TBST (TBS + 0.1% Tween-20). The following primary antibodies were used: anti-phospho(Ser505)-AKT (Cell Signal Technology (CST) 4054, 1:1,000), anti-AKT (CST 4691, 1:1,000), anti-phospho(Thr172)-AMPKα (CST 2535, 1:1,000), anti-phospho(Thr389)-p70 S6 kinase (CST 9206, 1:1,000), anti-GFP (CST 2956, 1:1,000), anti-phospho-p44/42 MAPK (Erk1/2) (CST 4370, 1:1,000) and anti-α-tubulin (clone 12G10, Developmental Studies Hybridoma Bank, used as an unpurified supernatant at 1:3,000; used as a loading control for all blots). Primary antibodies were diluted in TBST containing 5% BSA and incubated over night at 4°C. Secondary antibodies were HRP anti-rabbit IgG (CST 7074, 1:5,000) and HRP anti-mouse IgG (CST 7076, 1:5,000). Proteins were detected with Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific) or Supersignal West Femto Chemiluminescent Substrate (Thermo Scientific) using a LAS-3000 Imager (Fujifilm). Bands were quantified by densitometry using Image J. Quantifications reflect all experiments performed; representative blots from single experiments are shown.

Thin Layer Chromatography (TLC) for Triglycerides

Groups of 10 flies were used per sample. After CO2 anaesthesia the flies were placed in 100 µl of ice-cold chloroform:methanol (3:1). Samples were centrifuged for 3 min at 13,000 rpm at 4°C, and then flies were smashed with pestles followed by another centrifugation step. A set of standards were prepared using lard (Sainsbury’s) in chloroform:methanol (3:1) for quantification. Samples and standards were loaded onto a silica gel glass plate (Millipore), and a solvent mix of hexane:ethyl ether (4:1) was prepared as mobile phase. Once the solvent front reached the top of the plate, the plate was dried and stained with an oxidising staining reagent containing ceric ammonium heptamolybdate (CAM) (Sigma Aldrich). For visualization of the oxidised bands, plates were baked at 80°C for 20 min. Baked plates were imaged with a scanner and triglyceride bands were quantified by densitometry according to the measured standards using Image J.

Measurement of glucose, Trehalose and Glycogen

5–7-day-old male flies, kept at 29°C, were used for the analysis. Flies were starved for 1 hr on 1% agar supplemented with 2% phosphate buffered saline (PBS) at 29°C before being manually smashed in 75 μl TE + 0.1% Triton X-100 (Sigma Aldrich). three flies per sample were used. All samples were incubated at 75°C for 20 min and stored at −80°C. Samples were thawed prior to measurement and incubated at 65°C for 5 min to inactivate fly enzymes. A total of 10 μl per sample was loaded for different measurements into flat-bottom 96-well tissue culture plates. Each fly sample was measured four times, first diluted in water for calculation of background fly absorbance, second with glucose reagent (Sentinel Diagnostics) for the measurement of free glucose, third with glucose reagent plus trehalase (Sigma Aldrich) for trehalose measurement, and fourth with glucose reagent plus amyloglucosidase (Sigma Aldrich) for glycogen measurement. Plates were then incubated at 37°C for 1 hr before reading with a microplate reader (biochrom) at 492 nm. Quantities of glucose, trehalose and glycogen were calculated according to measured standards.

Respirometry

Respiration in flies was measured using a stop-flow gas-exchange system (Q-Box RP1LP Low Range Respirometer, Qubit Systems, Ontario, Canada, K7M 3L5). Ten flies from each genotype were put into an airtight glass tube and supplied with our standard fly food via a modified pipette tip. Each tube was provided with CO2-free air while the ‘spent’ air was concurrently flushed through the system and analysed for its CO2 and O2 content. All vials with flies were normalized to a control vial with food but no flies inside. In this way, evolved CO2 per chamber and consumed O2 per chamber were measured for each tube every ~44 min (the time required to go through each of the vials in sequence).

Flow cytometry

For flow cytometric analysis of plasmatocytes, 90 flies per sample per genotype were anaesthetized and mechanically dissociated through a 100 µm mesh with 2 mM EDTA in PBS (FACS buffer). The cell suspension is spun down and the resulting cell pellet was resuspended in 5 ml FACS buffer and again rinsed through a 100 µm mesh in a new tube. This washing step was repeated twice. Afterwards the cells were resuspended in 500 µl 2 mM EDTA and Fixable Viability Dye 780 (ebioscience #65-0865-18, 1:1000). Samples were acquired on a FACS Canto II (BD Biosciences) and analyzed with FlowJo analysis software.

Statistical analysis and handling of data

For real-time quantitative PCR, TLCs, MFI quantification, western blot quantifications and colorimetric measurements for glucose, trehalose and glycogen levels an unpaired t-test or one-way ANOVA was used to calculate statistical significance, as noted in the figure legends. Respirometer data was analysed with a Mann-Whitney test. Lifespan/Survival assays, where analysed with the Log-Rank and Wilcoxon test. Stars indicate statistical significance as followed: *p<0.05, **p<0.01 and ***p<0.001. All statistical tests were performed with Excel or GraphPad Prism software.

All replicates are biological. No outliers were omitted, and all replicates are included in quantitations (including in cases where a single representative experiment is shown). Flies were allocated into experimental groups according to their genotypes. Masking was not used. For survival experiments, typically, the 50% of flies that eclosed first from a given cross were used for an experiment. For smaller-scale experiments, flies were selected randomly from those of a given age and genotype.

Acknowledgements

We thank the Vienna Drosophila RNAi Center, the Bloomington Drosophila Stock Center, James Castelli-Gair Hombría, Ernst Hafen, Michael Taylor, Dan Hultmark, Nazif Alic, Bruce Edgar, and the FlyTrap collection at Yale University for flies. We are grateful to Rebecca Berdeaux, Günter Fritz, Marco Prinz, Katie Woodcock, Frederic Geissmann, and members of the South Kensington Fly Room for support, discussion and comments. We thank Maria Oberle for technical assistance. Work in the Dionne lab was supported by funding from BBSRC (BB/P000592/1, BB/L020122/2), MRC (MR/L018802/2), and the Wellcome Trust (207467/Z/17/Z). KK was supported by a DFG fellowship. JS was supported by BBSRC/GSK CASE studentship BB/L502169/1. FH was supported by the Neuromac Graduate School of the SFB/TRR167 and the DFG under Germany’s Excellence Strategy (CIBSS-EXC-2189-Project ID 390939984). OG was supported by ERC Starting Grant 337689. The Facility for Imaging by Light Microscopy (FILM) at Imperial College London is part-supported by funding from the Wellcome Trust (104931/Z/14/Z) and BBSRC (BB/L015129/1).

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Katrin Kierdorf, Email: katrin.kierdorf@uniklinik-freiburg.de.

Marc S Dionne, Email: m.dionne@imperial.ac.uk.

K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.

K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.

Funding Information

This paper was supported by the following grants:

  • Wellcome Investigator Award 207467/Z/17/Z to Marc S Dionne.

  • Biotechnology and Biological Sciences Research Council Research Grant BB/P000592/1 to Katrin Kierdorf, Pinar Ustaoglu, Marc S Dionne.

  • Biotechnology and Biological Sciences Research Council Research Grant BB/L020122/2 to Jessica Sharrock, Marc S Dionne, Crystal M Vincent.

  • Medical Research Council Research Grant MR/L018802/2 to Katrin Kierdorf, Marc S Dionne.

  • Deutsche Forschungsgemeinschaft Research fellowship KI-1876/1 to Katrin Kierdorf.

  • Biotechnology and Biological Sciences Research Council PhD studentship BB/L502169/1 to Jessica Sharrock.

  • Deutsche Forschungsgemeinschaft CIBSS-EXC-2189-Project ID 390939984 to Fabian Hersperger.

  • NeuroMac Graduate School of the SFB/TRR167 to Fabian Hersperger.

  • European Commission ERC starting grant 337689 to Olaf Groß.

  • FWF DASI_FWF01_P29638S to Daria E Siekhaus, Attila Gyoergy.

  • Medical Research Council Research Grant MR/R00997X/1 to Crystal M Vincent, Marc S Dionne.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Project administration.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Project administration.

Investigation.

Investigation.

Investigation.

Investigation.

Investigation, Methodology.

Resources, Methodology.

Resources, Methodology.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Project administration.

Additional files

Transparent reporting form

Data availability

Data has been made available on Zenodo, under the DOI https://doi.org/10.5281/zenodo.3608626.

The following dataset was generated:

Kierdorf F, Dionne MS. 2020. Raw data for Kierdorf et al. Zenodo.

References

  1. Agaisse H, Petersen UM, Boutros M, Mathey-Prevot B, Perrimon N. Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury. Developmental Cell. 2003;5:441–450. doi: 10.1016/S1534-5807(03)00244-2. [DOI] [PubMed] [Google Scholar]
  2. Amoyel M, Bach EA. Functions of the Drosophila JAK-STAT pathway: lessons from stem cells. Jak-Stat. 2012;1:176–183. doi: 10.4161/jkst.21621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ayyaz A, Li H, Jasper H. Haemocytes control stem cell activity in the Drosophila intestine. Nature Cell Biology. 2015;17:736–748. doi: 10.1038/ncb3174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bach EA, Ekas LA, Ayala-Camargo A, Flaherty MS, Lee H, Perrimon N, Baeg GH. GFP reporters detect the activation of the Drosophila JAK/STAT pathway in vivo. Gene Expression Patterns. 2007;7:323–331. doi: 10.1016/j.modgep.2006.08.003. [DOI] [PubMed] [Google Scholar]
  5. Baik M, Lee MS, Kang HJ, Park SJ, Piao MY, Nguyen TH, Hennighausen L. Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet. European Journal of Nutrition. 2017;56:569–579. doi: 10.1007/s00394-015-1101-0. [DOI] [PubMed] [Google Scholar]
  6. Beshel J, Dubnau J, Zhong Y. A leptin analog locally produced in the brain acts via a conserved neural circuit to modulate Obesity-Linked behaviors in Drosophila. Cell Metabolism. 2017;25:208–217. doi: 10.1016/j.cmet.2016.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Binari R, Perrimon N. Stripe-specific regulation of pair-rule genes by hopscotch, a putative jak family tyrosine kinase in Drosophila. Genes & Development. 1994;8:300–312. doi: 10.1101/gad.8.3.300. [DOI] [PubMed] [Google Scholar]
  8. Bland ML, Lee RJ, Magallanes JM, Foskett JK, Birnbaum MJ. AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Developmental Biology. 2010;344:293–303. doi: 10.1016/j.ydbio.2010.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Britton JS, Lockwood WK, Li L, Cohen SM, Edgar BA. Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Developmental Cell. 2002;2:239–249. doi: 10.1016/S1534-5807(02)00117-X. [DOI] [PubMed] [Google Scholar]
  10. Brown S, Hu N, Hombría JC. Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless. Current Biology. 2001;11:1700–1705. doi: 10.1016/S0960-9822(01)00524-3. [DOI] [PubMed] [Google Scholar]
  11. Buchon N, Broderick NA, Kuraishi T, Lemaitre B. Drosophila EGFR pathway coordinates stem cell proliferation and gut remodeling following infection. BMC Biology. 2010;8:152. doi: 10.1186/1741-7007-8-152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chakrabarti S, Dudzic JP, Li X, Collas EJ, Boquete JP, Lemaitre B. Remote control of intestinal stem cell activity by haemocytes in Drosophila. PLOS Genetics. 2016;12:e1006089. doi: 10.1371/journal.pgen.1006089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chen HW, Chen X, Oh SW, Marinissen MJ, Gutkind JS, Hou SX. Mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family. Genes & Development. 2002;16:388–398. doi: 10.1101/gad.955202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143:813–825. doi: 10.1016/j.cell.2010.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dodington DW, Desai HR, Woo M. JAK/STAT - Emerging players in metabolism. Trends in Endocrinology & Metabolism. 2018;29:55–65. doi: 10.1016/j.tem.2017.11.001. [DOI] [PubMed] [Google Scholar]
  16. Gyoergy A, Roblek M, Ratheesh A, Valoskova K, Belyaeva V, Wachner S, Matsubayashi Y, Sánchez-Sánchez BJ, Stramer B, Siekhaus DE. Tools allowing independent visualization and genetic manipulation of Drosophila melanogaster Macrophages and Surrounding Tissues. G3: Genes|Genomes|Genetics. 2018;8:845–857. doi: 10.1534/g3.117.300452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hou XS, Melnick MB, Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell. 1996;84:411–419. doi: 10.1016/S0092-8674(00)81286-6. [DOI] [PubMed] [Google Scholar]
  18. Jiang H, Patel PH, Kohlmaier A, Grenley MO, McEwen DG, Edgar BA. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell. 2009;137:1343–1355. doi: 10.1016/j.cell.2009.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jiang H, Grenley MO, Bravo MJ, Blumhagen RZ, Edgar BA. EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell. 2011;8:84–95. doi: 10.1016/j.stem.2010.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kim TH, Choi SE, Ha ES, Jung JG, Han SJ, Kim HJ, Kim DJ, Kang Y, Lee KW. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetologica. 2013;50:189–200. doi: 10.1007/s00592-011-0259-z. [DOI] [PubMed] [Google Scholar]
  21. Lizcano JM, Alrubaie S, Kieloch A, Deak M, Leevers SJ, Alessi DR. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Biochemical Journal. 2003;374:297–306. doi: 10.1042/bj20030577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Luo H, Rose PE, Roberts TM, Dearolf CR. The hopscotch jak kinase requires the raf pathway to promote blood cell activation and differentiation in Drosophila. Molecular Genetics and Genomics. 2002;267:57–63. doi: 10.1007/s00438-001-0632-7. [DOI] [PubMed] [Google Scholar]
  23. Mashili F, Chibalin AV, Krook A, Zierath JR. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes. 2013;62:457–465. doi: 10.2337/db12-0337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mavalli MD, DiGirolamo DJ, Fan Y, Riddle RC, Campbell KS, van Groen T, Frank SJ, Sperling MA, Esser KA, Bamman MM, Clemens TL. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. Journal of Clinical Investigation. 2010;120:4007–4020. doi: 10.1172/JCI42447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mensah LB, Davison C, Fan SJ, Morris JF, Goberdhan DC, Wilson C. Fine-Tuning of PI3K/AKT signalling by the tumour suppressor PTEN is required for maintenance of flight muscle function and mitochondrial integrity in ageing adult Drosophila melanogaster. PLOS ONE. 2015;10:e0143818. doi: 10.1371/journal.pone.0143818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Myllymäki H, Rämet M. JAK/STAT pathway in Drosophila immunity. Scandinavian Journal of Immunology. 2014;79:377–385. doi: 10.1111/sji.12170. [DOI] [PubMed] [Google Scholar]
  27. Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes. 2008;57:3211–3221. doi: 10.2337/db07-1062. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  28. Péan CB, Schiebler M, Tan SW, Sharrock JA, Kierdorf K, Brown KP, Maserumule MC, Menezes S, Pilátová M, Bronda K, Guermonprez P, Stramer BM, Andres Floto R, Dionne MS. Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infection. Nature Communications. 2017;8:14642. doi: 10.1038/ncomms14642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rajan A, Perrimon N. Drosophila cytokine unpaired 2 regulates physiological homeostasis by remotely controlling insulin secretion. Cell. 2012;151:123–137. doi: 10.1016/j.cell.2012.08.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. PNAS. 2012;109:21528–21533. doi: 10.1073/pnas.1215849110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stocker H, Andjelkovic M, Oldham S, Laffargue M, Wymann MP, Hemmings BA, Hafen E. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in akt/PKB. Science. 2002;295:2088–2091. doi: 10.1126/science.1068094. [DOI] [PubMed] [Google Scholar]
  32. Ulgherait M, Rana A, Rera M, Graniel J, Walker DW. AMPK modulates tissue and organismal aging in a non-cell-autonomous manner. Cell Reports. 2014;8:1767–1780. doi: 10.1016/j.celrep.2014.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vijayakumar A, Wu Y, Sun H, Li X, Jeddy Z, Liu C, Schwartz GJ, Yakar S, LeRoith D. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration. Diabetes. 2012;61:94–103. doi: 10.2337/db11-0814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vijayakumar A, Buffin NJ, Gallagher EJ, Blank J, Wu Y, Yakar S, LeRoith D. Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury. Endocrinology. 2013;154:3776–3783. doi: 10.1210/en.2013-1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Villarino AV, Kanno Y, O'Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nature Immunology. 2017;18:374–384. doi: 10.1038/ni.3691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Woodcock KJ, Kierdorf K, Pouchelon CA, Vivancos V, Dionne MS, Geissmann F. Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet. Immunity. 2015;42:133–144. doi: 10.1016/j.immuni.2014.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yan R, Small S, Desplan C, Dearolf CR, Darnell JE. Identification of a stat gene that functions in Drosophila development. Cell. 1996;84:421–430. doi: 10.1016/S0092-8674(00)81287-8. [DOI] [PubMed] [Google Scholar]
  38. Yang H, Hultmark D. Drosophila muscles regulate the immune response against wasp infection via carbohydrate metabolism. Scientific Reports. 2017;7:15713. doi: 10.1038/s41598-017-15940-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zhao X, Karpac J. Muscle directs diurnal energy homeostasis through a Myokine-Dependent hormone module in Drosophila. Current Biology. 2017;27:1941–1955. doi: 10.1016/j.cub.2017.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: K VijayRaghavan1

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

The influence of metabolism and lifestyle on muscle function is well known and documented. The role of muscle function in lifespan and metabolism is now, increasingly, being teased out. In this study, the authors investigate the JAK/STAT signalling pathway in Drosophila muscle and suggest that it is a critical regulator of lifespan and metabolism. Using genetic interventions, the measurement of lifespan and the analysis of behaviour, the authors show that the genes domeless and hopscotch link to AKT activity to affect metabolic regulation, and lifespan. They also suggest that signals from hemocytes play an important role, though the interpretation of this is not straightforward given the metabolic phenotype is not recapitulated by ablating hemocytes. In sum, the authors make a persuasive case for a link between muscle and lifespan, and the system which they use will increasingly valuable for further studies.

Decision letter after peer review:

Thank you for submitting your article "Muscle function and homeostasis require macrophage-derived cytokine inhibition of AKT activity in Drosophila" for consideration by eLife. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior and Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Kierdorf et al. investigate the JAK/STAT signalling pathway in Drosophila muscle as a critical regulator of lifespan and metabolism. The authors show some convincing data linking domeless and hopscotch to AKT activity, metabolic misregulation, and shortened life. Additional data suggest that hemocyte Upd1 is the primary signal. This link is less well supported, but the redundancy between Upd1-3 make these experiments difficult to interpret.

The manuscript needs substantial revision and the authors may want to consider reducing (or even dropping?) the metabolism part.

Essential revisions:

There are a some critical questions that need to be addressed.

1) What is the control line used in these studies? Were all of the fly stocks backcrossed to a parental line? Without backcrossing, the experiments are lacking proper genetic controls. At least for the lifespan studies, the differences observed are easily obtained by heterosis, especially for the lines with multiple transgenic elements. An alternative would have been to use the temperature control, since all studies used a thermogenetic approach, but there appears to be some leakage with the system (Figure 1—figure supplement 1D, although AKT and other metabolic parameters weren't measured). The dependency on only thermogenetic manipulations is a minor weakness, but adding a GeneSwitch or other inducible approach would greatly support the findings.

2) How did the authors determine a single vial of 20 flies would be sufficient to resolve 5% differences in lifespan? And what is a "lifespan effect size"? Do they mean a 5% change in median or mean lifespan? For fly studies, we typically see a requirement of >200 flies to detect 5-10% differences in mean lifespan. Additionally, the various lifespans are described as pooled independent experiments. This doesn't seem right. In Figure 1B, that would mean the experimental line was tested three separate times with less than 20 flies per trial. Individual vials within a single trial should not be considered independent replicates. The lifespan studies are mostly believable, but some of the studies would benefit from independent replication. For example, we don't concur with the conclusion from Figure 4F. The data there is not sufficient to claim a further reduction in longevity with upd2/3 knockouts in a plasmocyte-deleted line.

3) The magnitude of change in AKT levels sometimes seem inconsistent with the effects on lifespan (e.g., comparing Figures 1—figure supplement 1J-K, 1F-H, and Figure 2—figure supplement 1B-C).

4) It is arguable that the metabolic phenotype is due to the haemocyte activity, since it cannot be recapitulated by their ablation.

The authors claim that the phenotype observed upon muscle specific dome inhibition is not due to gut malfunction. They support this claim by assessing gut integrity through the "smurf" assay. However, gut integrity is not equivalent to gut functionality. To properly exclude the gut, the authors should consider crucial gut functions impacting metabolic homeostasis such as feeding, digestion, nutrient absorption or gut contractility. These aspects should be at least discussed.

5) The potential gut contribution to some aspects of the observed phenotype cannot be easily dismissed especially considering its endocrine functions, that can be independent to the gut barrier integrity. In this context, for instance, since dome is expressed by the gut muscular layers, its depletion could potentially trigger upd2 production, which in turn can activate AKH signalling, a known mediator of energy reserve mobilization and positive regulator of basal metabolism.

6) The authors conclude that haemocytes are the mediators of the UPD-dome-STAT-pAKT-foxo circuit in the muscles, since haemocyte ablation reduces STAT-GFP reporter activity. There are two problems here:

Firstly, the extent to which haemocyte ablation is achieved using the experimental conditions is unclear. Can the authors be sure they have removed all hemocytes? Secondly, despite the effects on STAT, hemocyte ablation has no effect on the metabolic phenotype, which implies the presence of an independent, unexplored mediator of dome activation (despite the title of the article which suggests hemocytes as the sole effector of muscle function and homeostasis).

7) The involvement of hemocytes is sustained only by the evidence of stat activation. In this context, a reduced lifespan, alone or in combination with UPDs mutants/IRs is not particularly informative, since it may just reflect the effect of immunosuppression, rather than be related to muscle function and homeostasis. It would be more informative, for example, to assess the effects on climbing activity.

8) While hemocyte ablation, or UPD suppression, reduces STAT-GFP readout, no information is provided on the effect on AKT, which appears to mostly recapitulate the different aspects of muscle dome suppression. If hemocytes are responsible for dome activation, their ablation would phenocopy domeΔ induced upregulation of pAKT in muscles.

If the proposed model is correct, the pAKT upregulation should be rescued by foxo-GFP expression.

9) Another crucial point is the origin of UPD ligands. Only targeted knock-down of all UPDs within the hemocyte population can pinpoint a crucial role for this population on the muscle. The authors should see if this is speedily feasible.

eLife. 2020 Jan 20;9:e51595. doi: 10.7554/eLife.51595.sa2

Author response


Essential revisions:

There are a some critical questions that need to be addressed.

1) What is the control line used in these studies? Were all of the fly stocks backcrossed to a parental line? Without backcrossing, the experiments are lacking proper genetic controls. At least for the lifespan studies, the differences observed are easily obtained by heterosis, especially for the lines with multiple transgenic elements. An alternative would have been to use the temperature control, since all studies used a thermogenetic approach, but there appears to be some leakage with the system (Figure 1—figure supplement 1D, although AKT and other metabolic parameters weren't measured). The dependency on only thermogenetic manipulations is a minor weakness, but adding a GeneSwitch or other inducible approach would greatly support the findings.

We apologise that the genetic backgrounds were not completely clear. We have revised the Materials and methods to clarify this—essentially, all lines were backcrossed onto our isogenic w1118 control line, except for lines already on another isogenic background that could then be independently compared, and all crosses were performed with driver females so that all the (male) experimental progeny flies would have a uniform X chromosome. This should eliminate the concern regarding heterosis. We agree that a nonthermogenetic system would be desirable as an adjunct to the Gal80tsapproach we have used, but our experience with the GeneSwitch system has been so negative (off-target effects of RU486, weak expression when the system works) that we now avoid its use. However, the manuscript does include non-thermogenetic approaches as well—for example, the Mhc-Gal4 experiments shown in S1.

2) How did the authors determine a single vial of 20 flies would be sufficient to resolve 5% differences in lifespan? And what is a "lifespan effect size"? Do they mean a 5% change in median or mean lifespan? For fly studies, we typically see a requirement of >200 flies to detect 5-10% differences in mean lifespan. Additionally, the various lifespans are described as pooled independent experiments. This doesn't seem right. In Figure 1B, that would mean the experimental line was tested three separate times with less than 20 flies per trial. Individual vials within a single trial should not be considered independent replicates. The lifespan studies are mostly believable, but some of the studies would benefit from independent replication. For example, we don't concur with the conclusion from Figure 4F. The data there is not sufficient to claim a further reduction in longevity with upd2/3 knockouts in a plasmocyte-deleted line.

The comment regarding experimental power is correct—our calculation was wrong because of underestimation of the variance of survival time. (Most of our experience in this regard is with animals dying of bacterial infection, which can show much lower survival variance.) The incorrect statement has been removed. We are fortunate that the survival effect we actually observe in these experiments is generally 25% or more, so that our cohort sizes are large enough for robust conclusions to be drawn. With regard to pooling independent survivals, this statement was in error, due to confusion among the authors regarding the nature of an experimental cohort. With regard to the specific experiment shown in Figure 4F, we have changed our discussion of the result to reflect the fact that we cannot tell whether longevity is further reduced.

3) The magnitude of change in AKT levels sometimes seem inconsistent with the effects on lifespan (e.g., comparing Figures 1—figure supplement 1J-K, 1F-H, and Figure 2—figure supplement 1B-C).

It’s true that the effects we see on lifespan do not map in any obvious, linear way onto the effect on AKT levels (although, in general, manipulations that give smaller effects on AKT tend to give smaller effects on lifespan—the only real exception to this is Mef2-Gal80ts, which gives a smaller effect on lifespan than would be expected from its effect on AKT abundance). We don’t know why, exactly, beyond the (trivial) observation that dome-AKT signaling is not the only regulator of lifespan. However, our epistasis experiments show clearly that the effect on AKT is an important mediator of the effect of dome inhibition—this is the central point of our work.

4) It is arguable that the metabolic phenotype is due to the haemocyte activity, since it cannot be recapitulated by their ablation.

The authors claim that the phenotype observed upon muscle specific dome inhibition is not due to gut malfunction. They support this claim by assessing gut integrity through the "smurf" assay. However, gut integrity is not equivalent to gut functionality. To properly exclude the gut, the authors should consider crucial gut functions impacting metabolic homeostasis such as feeding, digestion, nutrient absorption or gut contractility. These aspects should be at least discussed.

We now discuss these points in the Discussion. We also now provide feeding data for 24BGal80ts> domeΔanimals, showing that they consume the same amount of food as the control genotype (Figure 1—figure supplement 1S).

5) The potential gut contribution to some aspects of the observed phenotype cannot be easily dismissed especially considering its endocrine functions, that can be independent to the gut barrier integrity. In this context, for instance, since dome is expressed by the gut muscular layers, its depletion could potentially trigger upd2 production, which in turn can activate AKH signalling, a known mediator of energy reserve mobilization and positive regulator of basal metabolism.

The reviewer is correct about the role of AKH signaling as a known mediator of energy mobilization. We have tested the specific scenario described (upd2 > AKH) by assaying expression of AKH and known and suspected AKH target genes in 24B-Gal80ts>domeΔanimals; these data are included as Figure 3—figure supplement 1I-M. In general, though these data are consistent with there being some change in AKH signaling, they do not suggest a strong effect. In a more general sense, we do now discuss other potential contributions of the gut.

6) The authors conclude that haemocytes are the mediators of the UPD-dome-STAT-pAKT-foxo circuit in the muscles, since haemocyte ablation reduces STAT-GFP reporter activity. There are two problems here:

Firstly, the extent to which haemocyte ablation is achieved using the experimental conditions is unclear. Can the authors be sure they have removed all hemocytes? Secondly, despite the effects on STAT, hemocyte ablation has no effect on the metabolic phenotype, which implies the presence of an independent, unexplored mediator of dome activation (despite the title of the article which suggests hemocytes as the sole effector of muscle function and homeostasis).

We have now included experimental validation of the plasmatocyte ablation by imaging and flow cytometry (Figure 4—figure supplement 1A, B); we see that almost all (>95%) of plasmatocytes are eliminated. We agree with the reviewer regarding the role of plasmatocytes: we have changed the title to avoid confusion. In the main text we clearly state that plasmatocytes are one relevant source of signal, but they are probably not the only source in wild-type animals (and are certainly not the only source in plasmatocyte-ablated or upd1-knockdown animals).

7) The involvement of hemocytes is sustained only by the evidence of stat activation. In this context, a reduced lifespan, alone or in combination with UPDs mutants/IRs is not particularly informative, since it may just reflect the effect of immunosuppression, rather than be related to muscle function and homeostasis. It would be more informative, for example, to assess the effects on climbing activity.

We have assayed climbing activity in plasmatocyte-ablated flies. We found a clear reduction in their climbing activity after hemocyte ablation compared to the control genotype, in line with our findings that hemocyte ablation further results with the appearance of lipid inclusions in muscle of these animals. These data are now included as Figure 4—figure supplement 1C.

8) While hemocyte ablation, or UPD suppression, reduces STAT-GFP readout, no information is provided on the effect on AKT, which appears to mostly recapitulate the different aspects of muscle dome suppression. If hemocytes are responsible for dome activation, their ablation would phenocopy domeΔ induced upregulation of pAKT in muscles.

If the proposed model is correct, the pAKT upregulation should be rescued by foxo-GFP expression.

Due to limitations in time we were not able to combine plasmatocyte ablation with the foxo-GFP construct. The reviewer is absolutely right that foxo-GFP should rescue the high abundance of pAKT; this is shown as Figure 3—figure supplement 1D.

9) Another crucial point is the origin of UPD ligands. Only targeted knock-down of all UPDs within the hemocyte population can pinpoint a crucial role for this population on the muscle. The authors should see if this is speedily feasible.

We agree that this would be desirable, but we have been unable to combine all the required knockdowns in a single fly in the time available to us.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Kierdorf F, Dionne MS. 2020. Raw data for Kierdorf et al. Zenodo. [DOI]

    Supplementary Materials

    Transparent reporting form

    Data Availability Statement

    Data has been made available on Zenodo, under the DOI https://doi.org/10.5281/zenodo.3608626.

    The following dataset was generated:

    Kierdorf F, Dionne MS. 2020. Raw data for Kierdorf et al. Zenodo.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES